Literature DB >> 23105525

New dimensions in vaccinology: A new insight.

D Tomar1, V Chattree, V Tripathi, A A Khan, A R Bakshi, D N Rao.   

Abstract

The development of vaccines to prevent infectious diseases has been one of the most important contributions of biomedical sciences. Increasing understanding in biochemistry, molecular biology, molecular genetics and related fields have provided an opportunity for the development of new generation vaccines that are based on rational design approaches. This is possible because of proper understanding of the microbial-genetics, biochemistry, host-pathogen interaction and recent developments in molecular immunology. Another important improvement made in the quality of vaccine production is the incorporation of immunomodulators or adjuvants with modified delivery vehicles viz liposomes, Iscoms and microspheres apart from alum being used as a gold standard. This article reviews the art of vaccination from Jenner period to present day context highlighting all the developments made at each stage of the vaccine development. Various criteria have been discussed regarding the selection of epitopes that expand B & T cells, its linkage with other accessory cells of the immune system, means to overcome MHC linked immune unresponsiveness, enhanced antigen processing and presentations that specially induce either helper or cytotoxic or mucosal immune responses were critically discussed.

Entities:  

Keywords:  Adjuvant; Antibody; Antigen; Epitope; Iscoms; Liposomes; MHC; Peptide; Vaccine; and Microsphere

Year:  2005        PMID: 23105525      PMCID: PMC3454171          DOI: 10.1007/BF02893073

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  90 in total

1.  Identification of immunodominant epitope of F1 antigen of Yersinia pestis.

Authors:  L Sabhnani; D N Rao
Journal:  FEMS Immunol Med Microbiol       Date:  2000-02

Review 2.  Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines.

Authors:  Z Li
Journal:  Semin Immunol       Date:  1997-10       Impact factor: 11.130

Review 3.  Development of artificial vaccines against HIV using defined epitopes.

Authors:  J A Berzofsky
Journal:  FASEB J       Date:  1991-07       Impact factor: 5.191

4.  Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target.

Authors:  Monika Manocha; Pramod Chandra Pal; K T Chitralekha; Beena Elizabeth Thomas; Vinita Tripathi; Siddhartha Dutta Gupta; Ramesh Paranjape; Smita Kulkarni; D Nageswara Rao
Journal:  Vaccine       Date:  2005-07-27       Impact factor: 3.641

5.  New age adjuvants and delivery systems for subunit vaccines.

Authors:  S Kurella; M Manocha; L Sabhnani; B Thomas; D N Rao
Journal:  Indian J Clin Biochem       Date:  2000-08

6.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

7.  Preventive and therapeutic effect of tumor derived heat shock protein, gp96, in an experimental prostate cancer model.

Authors:  S P Yedavelli; L Guo; M E Daou; P K Srivastava; A Mittelman; R K Tiwari
Journal:  Int J Mol Med       Date:  1999-09       Impact factor: 4.101

8.  Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses.

Authors:  M E Baca-Estrada; M M Foldvari; M M Snider; K K Harding; B B Kournikakis; L A Babiuk; P P Griebel
Journal:  Vaccine       Date:  2000-04-28       Impact factor: 3.641

9.  Vitamin E adjuvant formulations in mice.

Authors:  R P Tengerdy; N G Lacetera
Journal:  Vaccine       Date:  1991-03       Impact factor: 3.641

10.  Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes.

Authors:  W J Storkus; H J Zeh; M J Maeurer; R D Salter; M T Lotze
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.